Response to Cohen et al
Rae F. Bell, Eija A. Kalso
PAIN Reports · 2019
doi:10.1097/pr9.0000000000000731 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
We thank Drs. Cohen, Schwenk, and Viscusi for their letter with information about the recently published guidelines on the use of ketamine for acute pain and chronic noncancer pain.1 We commend the American Society of Regional Anesthesia & Pain Medicine and the American Academy of Pain Medicine for this important initiative. We trust that the guidelines will be regularly updated, in accordance with best current evidence and clinical expertise. Disclosures The authors have no conflict of interest to declare.
Abstract licence: CC BY-NC-ND
References1
1 more reference, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.